Amphastar Pharmaceuticals Competitors and Similar CompaniesClear all
Amphastar Pharmaceuticals's competitors and similar companies include Synthon, Vertex Pharmaceuticals, Esteve Quimica and Livzon Pharmaceutical Group.
 Amphastar Pharmaceuticals Amphastar Pharmaceuticals is a pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal, and inhalation products. |  Synthon Synthon is a pharmaceutical company that develops, manufactures, and commercializes generic medicines. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Esteve Quimica Esteve Quimica is a company developing, manufacturing, and marketing oral and injectable-non-sterile APIs (active pharmaceutical ingredient). |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 1996 | Founding Date 1991 | Founding Date 1989 | Founding Date 1966 | Founding Date 1985 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Rancho Cucamonga, US HQ Nanjing Shi, CN | Locations Barcelona, ES HQ Shaoxing Shi, CN Barcelona, ES Celrà, ES | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | ||
Employees | Employees 1,7619% increase | Employees 1,3301% increase | Employees 5,40013% increase | Employees 934 | Employees 9,067 |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) N/A | Valuation ($) 121.4 b | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $719.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $12b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods $363.8m (FY, 2025) | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit $356.1m (FY, 2025) | Gross profit N/A | Gross profit $10.4b (FY, 2025) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income $98.1m (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income ¥2.4b (FY, 2025) |
Operating ⚠ | |||||
Products | Products 20 (Q3, 2021) | Products N/A | Products 6 (FY, 2022) | Products N/A | Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Synthon
HQ
Nijmegen, NL
Employees
1,330↑ 1% increase
Synthon is a pharmaceutical company that develops, manufactures, and commercializes generic medicines.
View companyVertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View companyEsteve Quimica
HQ
Barcelona, ES
Employees
934
Esteve Quimica is a company developing, manufacturing, and marketing oral and injectable-non-sterile APIs (active pharmaceutical ingredient).
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company